Less Toxicity Seen With MRI-Guided SBRT for Prostate Cancer

WEDNESDAY, Feb. 23, 2022 (HealthDay News) -- In men receiving treatment for localized prostate cancer, the incidence of acute grade ≥2 genitourinary (GU) toxicity is lower with magnetic resonance imaging (MRI)-guided versus computed tomography (CT)-guided stereotactic body radiotherapy (SBRT), according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 17 to 19 in San Francisco.
Amar Upadhyaya Kishan, M.D., from the University of California in Los Angeles, and colleagues conducted an interim analysis of the phase 3 MIRAGE trial, which compared MRI and CT guidance among men undergoing SBRT for localized prostate cancer with a pragmatic primary end point of acute grade ≥2 GU toxicity. One hundred patients were eligible for evaluation (51 in the CT arm and 49 in the MRI arm).
The researchers found that men receiving MRI-guided SBRT had a significantly reduced incidence of acute grade ≥2 GU toxicity (47.1 versus 22.4 percent). Men receiving MRI-guided SBRT also had a significantly reduced incidence of acute grade ≥2 gastrointestinal (GI) toxicity (13.7 versus 0 percent). At one month after SBRT, but not at three months after, the increase in International Prostate Symptom Score was significantly higher in men receiving CT-guided SBRT.
"MRI-guidance offers a statistically significant reduction in acute grade GU as well as GI toxicity for prostate SBRT," a coauthor said in a statement. "Our final results are expected later this year, but we are extremely optimistic by what we're seeing, and hope this technology will soon begin to offer men undergoing radiotherapy for prostate cancer better outcomes."
Several authors disclosed financial ties to the pharmaceutical and medical device industries.
Related Posts
Cystatin C-Based Equation Accurate for Estimating Glomerular Filtration Rate
THURSDAY, Jan. 26, 2023 (HealthDay News) -- A cystatin C (cys)-based European...
Is the Mumps Vaccine Becoming Less Effective?
THURSDAY, Dec. 2, 2021 (HealthDay News) -- Children and teenagers vaccinated...
Un nuevo tratamiento mejora mucho la supervivencia de los niños con un agresivo tumor cerebral
VIERNES, 10 de diciembre de 2021 (HealthDay News) -- Los niños con un...
Más evidencias de que la infección con la COVID conlleva riesgos cardiacos a largo plazo
JUEVES, 10 de febrero de 2022 (HealthDay News) -- Una investigación reciente...
